Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: Thermo fisher - The Real Truth

The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down

These five stocks are outperforming their beaten-down sectors on strong fundamentals, not hype, making them momentum plays worth watching now.

MarketBeat

The Often-Missed Corner of Healthcare That Wall Street Is Loving

Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies.

MarketBeat

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

Barchart

Institutions Love These 3 Companies, Should You As Well?

Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.

MarketBeat

These 3 Stocks Are Using Buybacks to Signal Market Confidence

Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?

MarketBeat

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities

Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other performance-based payments.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Thermo Fisher Integrates OpenAI To Speed Drug Development

Thermo Fisher Scientific Inc. (NYSE:TMO) stock is trading higher on Thursday. The company announced plans to use artificial intelligence (AI) with OpenAI.

Benzinga

What to Expect From Thermo Fisher’s Q3 2025 Earnings Report

Thermo Fisher is scheduled to report its Q3 earnings later this month. What should you expect from its upcoming report?

Barchart

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Thermo Fisher Scientific Inc. (NYSE:TMO) is tapping the U.S. investment-grade bond market with a four-part, dollar-denominated offering, as companies move to secure funding ahead of a potential U.S. government shutdown.

Benzinga

This Thermo Fisher Scientific Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Benzinga

Detailed findings from AP investigation into how US tech firms enabled China's digital police state

An AP investigation reveals that U.S. technology companies to a large degree designed and built China’s surveillance state, playing a far greater role in enabling human rights abuses than previously known

The Independent UK

US tech companies enabled the surveillance and detention of hundreds of thousands in China

The Independent UK

Is Thermo Fisher Scientific Stock Underperforming the Dow?

Thermo Fisher Scientific has lagged behind the Dow Jones Industrial over the past year, but analysts maintain a strong bullish outlook on its future performance.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. (NYSE:TMO) be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strategic acquisitions and robust growth potential. William Blair initiated coverage on Tuesday on Thermo Fisher Scientific, citing a strong…

Barchart

Is Wall Street Bullish or Bearish on Thermo Fisher Scientific Stock?

While Thermo Fisher Scientific has underperformed the broader market over the past year, Wall Street analysts continue to hold a bullish view of the stock’s long-term prospects.

Benzinga

Why Thermo Fischer Stock Is Rising Wednesday

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, beating the street view of $5.23.

Barchart

Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report

Thermo Fisher Scientific is poised to release its second-quarter results later this month, and analysts project a single-digit earnings drop.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

These are the Fortune 500 companies that have active contracts with ICE

From AT&T to FedEx, these are the organizations contracting with the Immigration and Customs Enforcement.

Barchart

Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents

While TMO stock has represented one of the biggest market losers, a sentiment reversal could be in the works.

Barchart

Are Wall Street Analysts Bullish on Thermo Fisher Scientific Stock?

Although Thermo Fisher Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

The Guardian - UK

‘Half the place would be blown to bits’: the Irish villages under threat from Trump’s tariffs

Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on the sector

MarketBeat

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

Barchart

How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Barchart

Thermo Fisher Scientific Stock: Is TMO Underperforming the Healthcare Sector?

Thermo Fisher Scientific recently underperformed the healthcare sector, but Wall Street analysts are bullish about the stock’s prospects.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.